• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HTX
Click for more information
0.00% 0.1¢

HEALTHLINX LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HTXResults of Meeting27/09/12
HTXChairman's Address to Shareholders27/09/12
HTXAppendix 3B13/09/12
HTXAppendix 3B03/09/12
HTXUS Patent Granted to HealthLinx for AGR2 BiomarkerPRICE SENSITIVE03/09/12
HTXAppendix 4E and Annual Report 2012PRICE SENSITIVE31/08/12
HTXNotice of Extraordinary General Meeting/Proxy Form27/08/12
HTXAppendix 3B24/08/12
HTXSale of IP provides Presence in US markets for assetsPRICE SENSITIVE03/08/12
HTXTrading HaltPRICE SENSITIVE03/08/12
HTXAppendix 4C relodged to correct date error27/07/12
HTXAppendix 3B26/07/12
HTXAppendix 4C and CommentaryPRICE SENSITIVE26/07/12
HTXAppendix 3B13/07/12
HTXAppendix 3B09/07/12
HTXOvPlex patent granted in SingaporePRICE SENSITIVE06/07/12
HTXAppendix 3B04/07/12
HTXVanessa Waddell appointed General Manager of HealthLinx29/06/12
HTXAppendix 3B27/06/12
HTXPositive Findings in South Korean Study for OvPlexPRICE SENSITIVE27/06/12
HTXAppendix 3B21/06/12
HTXResults of Meeting20/06/12
HTXFinal directors interest notice by two14/06/12
HTXHealthLinx Board Changes14/06/12
HTXAppendix 3B07/06/12
HTXAppendix 3B31/05/12
HTXAppendix 3B24/05/12
HTXNotice of Extraordinary General Meeting/Proxy Form18/05/12
HTXAppendix 3B16/05/12
HTXOvPlex distribution expands into IndiaPRICE SENSITIVE15/05/12
HTXAppendix 3B02/05/12
HTXAppendix 4C - quarterlyPRICE SENSITIVE19/04/12
HTXNew OvPlex Publication and New Prospective TrialPRICE SENSITIVE29/03/12
HTXAppendix 3B28/03/12
HTXAppendix 3B20/03/12
HTXPivotal KFDA Study for OvPlex Ready to CommencePRICE SENSITIVE20/03/12
HTXAppendix 3B16/03/12
HTXAppendix 3B05/03/12
HTXAppendix 3B29/02/12
HTXAppendix 4D and half year financial statements December 2011PRICE SENSITIVE28/02/12
HTXAppendix 3B27/02/12
HTXAppendix 3B for ESOP Options20/02/12
HTXAppendix 3B15/02/12
HTXNovel biomarker that predicts clinical outcome validatedPRICE SENSITIVE15/02/12
HTXAppendix 3B09/02/12
HTXAppendix 3B31/01/12
HTXResults of Meeting31/01/12
HTXChairman's Address to Shareholders31/01/12
HTXAppendix 3B25/01/12
HTXAppendix 4C - quarterlyPRICE SENSITIVE25/01/12
HTXSection 708A Notice23/01/12
HTXAppendix 3B23/01/12
HTXNotice of Extraordinary General Meeting/Proxy Form29/12/11
HTXAppendix 3B22/12/11
HTXRecruitment for OvPlex second trial to be finalised earlyPRICE SENSITIVE16/12/11
HTXAppendix 3B13/12/11
HTXSection 708A Notice13/12/11
HTXSection 708A Notice12/12/11
HTXAppendix 3B12/12/11
HTXCleansing Notice under Section 708(12C)(e)08/12/11
HTXConvertible Note with La Jolla Cove Investors Inc for $9mPRICE SENSITIVE08/12/11
HTXCancellation of unquoted options01/12/11
HTXSection 708A Notice01/12/11
HTXAppendix 3B01/12/11
HTXHealthLinx Intellectual Property portfolio strengthenedPRICE SENSITIVE01/12/11
HTXSection 708A Notice25/11/11
HTXAppendix 3B25/11/11
HTXSection 708A Notice23/11/11
HTXAppendix 3B23/11/11
HTXBinding HOA with Oryzon Genomics to distribute OvplexPRICE SENSITIVE22/11/11
HTXHealthLinx CEO to resign as of 30th June 2012PRICE SENSITIVE16/11/11
HTXProstate collaboration to continue with Garvan InstitutePRICE SENSITIVE10/11/11
HTXSection 708A Notice07/11/11
HTXAppendix 3B07/11/11
HTXSection 708A Notice04/11/11
HTXAppendix 3B04/11/11
HTXResults of Meeting02/11/11
HTXChairman's Address to Shareholders02/11/11
HTXAppendix 4C - quarterlyPRICE SENSITIVE28/10/11
HTXOvPlex patent granted in Hong KongPRICE SENSITIVE26/10/11
HTXOvPlex patent granted in Hong KongPRICE SENSITIVE26/10/11
HTXSection 708A Notice25/10/11
HTXAppendix 3B25/10/11
HTXAppendix 3B19/10/11
HTXSection 708A Notice19/10/11
HTXAppendix 3B14/10/11
HTXSection 708A Notice14/10/11
HTXOvPlex trademark granted in ChinaPRICE SENSITIVE11/10/11
HTXSecond OvPlex trial reports increased diagnostic efficiencyPRICE SENSITIVE11/10/11
HTXSection 708A Notice10/10/11
HTXAppendix 3B10/10/11
HTXINEX to expand OvPlex distribution to MalaysiaPRICE SENSITIVE07/10/11
HTXSection 708A Notice04/10/11
HTXAppendix 3B04/10/11
HTXAnnual Report to shareholders30/09/11
HTXNotice of Annual General Meeting/Proxy Form30/09/11
HTXShareholder UpdatePRICE SENSITIVE27/09/11
HTXSection 708A Notice23/09/11
HTXAppendix 3B23/09/11
HTXSection 708A Notice21/09/11
HTXResults of Meeting
27/09/12
HTXChairman's Address to Shareholders
27/09/12
HTXAppendix 3B
13/09/12
HTXAppendix 3B
03/09/12
HTXUS Patent Granted to HealthLinx for AGR2 Biomarker
03/09/12PRICE SENSITIVE
HTXAppendix 4E and Annual Report 2012
31/08/12PRICE SENSITIVE
HTXNotice of Extraordinary General Meeting/Proxy Form
27/08/12
HTXAppendix 3B
24/08/12
HTXSale of IP provides Presence in US markets for assets
03/08/12PRICE SENSITIVE
HTXTrading Halt
03/08/12PRICE SENSITIVE
HTXAppendix 4C relodged to correct date error
27/07/12
HTXAppendix 3B
26/07/12
HTXAppendix 4C and Commentary
26/07/12PRICE SENSITIVE
HTXAppendix 3B
13/07/12
HTXAppendix 3B
09/07/12
HTXOvPlex patent granted in Singapore
06/07/12PRICE SENSITIVE
HTXAppendix 3B
04/07/12
HTXVanessa Waddell appointed General Manager of HealthLinx
29/06/12
HTXAppendix 3B
27/06/12
HTXPositive Findings in South Korean Study for OvPlex
27/06/12PRICE SENSITIVE
HTXAppendix 3B
21/06/12
HTXResults of Meeting
20/06/12
HTXFinal directors interest notice by two
14/06/12
HTXHealthLinx Board Changes
14/06/12
HTXAppendix 3B
07/06/12
HTXAppendix 3B
31/05/12
HTXAppendix 3B
24/05/12
HTXNotice of Extraordinary General Meeting/Proxy Form
18/05/12
HTXAppendix 3B
16/05/12
HTXOvPlex distribution expands into India
15/05/12PRICE SENSITIVE
HTXAppendix 3B
02/05/12
HTXAppendix 4C - quarterly
19/04/12PRICE SENSITIVE
HTXNew OvPlex Publication and New Prospective Trial
29/03/12PRICE SENSITIVE
HTXAppendix 3B
28/03/12
HTXAppendix 3B
20/03/12
HTXPivotal KFDA Study for OvPlex Ready to Commence
20/03/12PRICE SENSITIVE
HTXAppendix 3B
16/03/12
HTXAppendix 3B
05/03/12
HTXAppendix 3B
29/02/12
HTXAppendix 4D and half year financial statements December 2011
28/02/12PRICE SENSITIVE
HTXAppendix 3B
27/02/12
HTXAppendix 3B for ESOP Options
20/02/12
HTXAppendix 3B
15/02/12
HTXNovel biomarker that predicts clinical outcome validated
15/02/12PRICE SENSITIVE
HTXAppendix 3B
09/02/12
HTXAppendix 3B
31/01/12
HTXResults of Meeting
31/01/12
HTXChairman's Address to Shareholders
31/01/12
HTXAppendix 3B
25/01/12
HTXAppendix 4C - quarterly
25/01/12PRICE SENSITIVE
HTXSection 708A Notice
23/01/12
HTXAppendix 3B
23/01/12
HTXNotice of Extraordinary General Meeting/Proxy Form
29/12/11
HTXAppendix 3B
22/12/11
HTXRecruitment for OvPlex second trial to be finalised early
16/12/11PRICE SENSITIVE
HTXAppendix 3B
13/12/11
HTXSection 708A Notice
13/12/11
HTXSection 708A Notice
12/12/11
HTXAppendix 3B
12/12/11
HTXCleansing Notice under Section 708(12C)(e)
08/12/11
HTXConvertible Note with La Jolla Cove Investors Inc for $9m
08/12/11PRICE SENSITIVE
HTXCancellation of unquoted options
01/12/11
HTXSection 708A Notice
01/12/11
HTXAppendix 3B
01/12/11
HTXHealthLinx Intellectual Property portfolio strengthened
01/12/11PRICE SENSITIVE
HTXSection 708A Notice
25/11/11
HTXAppendix 3B
25/11/11
HTXSection 708A Notice
23/11/11
HTXAppendix 3B
23/11/11
HTXBinding HOA with Oryzon Genomics to distribute Ovplex
22/11/11PRICE SENSITIVE
HTXHealthLinx CEO to resign as of 30th June 2012
16/11/11PRICE SENSITIVE
HTXProstate collaboration to continue with Garvan Institute
10/11/11PRICE SENSITIVE
HTXSection 708A Notice
07/11/11
HTXAppendix 3B
07/11/11
HTXSection 708A Notice
04/11/11
HTXAppendix 3B
04/11/11
HTXResults of Meeting
02/11/11
HTXChairman's Address to Shareholders
02/11/11
HTXAppendix 4C - quarterly
28/10/11PRICE SENSITIVE
HTXOvPlex patent granted in Hong Kong
26/10/11PRICE SENSITIVE
HTXOvPlex patent granted in Hong Kong
26/10/11PRICE SENSITIVE
HTXSection 708A Notice
25/10/11
HTXAppendix 3B
25/10/11
HTXAppendix 3B
19/10/11
HTXSection 708A Notice
19/10/11
HTXAppendix 3B
14/10/11
HTXSection 708A Notice
14/10/11
HTXOvPlex trademark granted in China
11/10/11PRICE SENSITIVE
HTXSecond OvPlex trial reports increased diagnostic efficiency
11/10/11PRICE SENSITIVE
HTXSection 708A Notice
10/10/11
HTXAppendix 3B
10/10/11
HTXINEX to expand OvPlex distribution to Malaysia
07/10/11PRICE SENSITIVE
HTXSection 708A Notice
04/10/11
HTXAppendix 3B
04/10/11
HTXAnnual Report to shareholders
30/09/11
HTXNotice of Annual General Meeting/Proxy Form
30/09/11
HTXShareholder Update
27/09/11PRICE SENSITIVE
HTXSection 708A Notice
23/09/11
HTXAppendix 3B
23/09/11
HTXSection 708A Notice
21/09/11
refresh Created with Sketch. REFRESH
 

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.